Dashboard
Manage Tickers

JYNT JOINT Corp

Nasdaq thejoint.com


$ 8.24 $ -0.27 (-3.18 %)    

Thursday, 23-Oct-2025 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.70 $ 5.09 (0.84 %)
DIA $ 467.20 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.38 $ -0.63 (-0.68 %)
GLD $ 378.90 $ 1.51 (0.4 %)
$ 8.23
$ 8.49
$ 8.00 x 1
$ 8.90 x 20
$ 8.20 - $ 8.50
$ 8.01 - $ 13.47
63,639
na
126.28M
$ 1.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-14-2025 12-31-2024 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 03-08-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 09-26-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 03-10-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-12-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 03-05-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-07-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 03-06-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-11-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-10-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-12-2017 03-31-2017 10-Q
35 03-10-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-12-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-17-2016 12-31-2015 10-K
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

b-riley-securities-maintains-buy-on-joint-lowers-price-target-to-18
B. Riley Securities Maintains Buy on Joint...
08/08/2025 12:56:58

B. Riley Securities analyst Jeff Van Sinderen maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $20 ...

joint-q2-eps-001-beats-001-estimate-sales-1327m-miss-1332m-estimate
Joint Q2 EPS $0.01 Beats $(0.01) Estimate,...
08/07/2025 20:55:15

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

joint-corp-says-it-expects-to-restate-fy24-and-q1-2025-financial-statements-due-to-overestimated-noncash-impairment-charges
Joint Corp Says It Expects To Restate FY24...
07/30/2025 21:34:25

- SEC Filing 

the-joint-sells-31-clinics-for-83m-gains-control-of-profitable-northwest-franchise-region
The Joint Sells 31 Clinics for $8.3M, Gain...
07/07/2025 11:07:27

The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network...

the-joint-sells-31-clinics-to-largest-franchisee-expands-northwest-territory-ahead-of-june-30-deal-close
The Joint Sells 31 Clinics to Largest Fran...
06/25/2025 11:07:53

The Joint Corp. (NASDAQ:JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network...

the-joint-corp-appoints--scott-j-bowman-as-chief-financial-officer-effective-june-10-2025
The Joint Corp. Appoints Scott J. Bowman ...
06/10/2025 20:10:33

the-joint-corp-approves-5m-stock-buyback-program-starting-august-2025
The Joint Corp. Approves $5M Stock Buyback...
06/05/2025 11:08:42

The Joint Corp. (NASDAQ:JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, ...

lake-street-maintains-buy-on-joint-lowers-price-target-to-16
Lake Street Maintains Buy on Joint, Lowers...
05/09/2025 14:48:13

Lake Street analyst Ryan Meyers maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $20 to $16.

joint-q1-eps-005-beats-001-estimate-sales-1308m-beat-1302m-estimate
Joint Q1 EPS $0.05 Beats $0.01 Estimate, S...
05/08/2025 20:36:34

Joint (NASDAQ:JYNT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.01 by 400 pe...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

the-joint-corp-sees-fy25-system-wide-sales-550m-570m
The Joint Corp. Sees FY25 System-Wide Sale...
03/13/2025 20:13:56

2025 GuidanceThe company provided the following guidance for 2025.System-wide sales are expected to be between $550 million and...

joint-q4-eps-018-misses-001-estimate-sales-1445m-miss-2899m-estimate
Joint Q4 EPS $(0.18) Misses $0.01 Estimate...
03/13/2025 20:10:16

Joint (NASDAQ:JYNT) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $0.01 by 1900...

earnings-scheduled-for-march-13-2025
Earnings Scheduled For March 13, 2025
03/13/2025 08:32:19

why-f5-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket
Why F5 Shares Are Trading Higher By 15%; H...
01/29/2025 10:03:26

why-imac-holdings-shares-are-trading-higher-by-over-108-here-are-20-stocks-moving-premarket
Why IMAC Holdings Shares Are Trading Highe...
01/28/2025 10:06:08

the-joint-corp-performed-147m-patient-visits-in-2024-compared-to-136m-in-2023
The Joint Corp Performed 14.7M Patient Vis...
01/16/2025 12:23:13

2024 Full Year Operating HighlightsPerformed 14.7 million patient visits, compared to 13.6 million in 2023.Treated 957,000 new ...

roth-mkm-maintains-buy-on-joint-lowers-price-target-to-15
Roth MKM Maintains Buy on Joint, Lowers Pr...
11/08/2024 17:23:23

Roth MKM analyst George Kelly maintains Joint (NASDAQ:JYNT) with a Buy and lowers the price target from $16 to $15.

joint-q3-2024-adj-eps-004-beats-001-estimate-sales-30198m-beat-28376m-estimate
Joint Q3 2024 Adj. EPS $0.04 Beats $0.01 E...
11/07/2024 23:49:53

Joint (NASDAQ:JYNT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 pe...

joint-corp-fy-2024-system-wide-sales-are-expected-to-be-between-525-million-and-535-million
Joint Corp. FY 2024 System-wide sales are ...
11/07/2024 21:48:14

Joint (NASDAQ:JYNT) System-wide sales are expected to be between $525 million and $535 million.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION